Opioid Working Group
Coordinator:
Fernando Neira Queen.
Vocals:
J. Luisa Ortega García (spokesperson for the Board), Sebastián Perales Recio. Ignacio Velazquez Rivera.
Coordinator:
Fernando Neira Queen.
Vocals:
J. Luisa Ortega García (spokesperson for the Board), Sebastián Perales Recio. Ignacio Velazquez Rivera.
Diana González‐Bermejo Pilar Rayón‐Iglesias Alfonso Rodríguez‐Pascual Arturo Álvarez‐Gutiérrez Ana Fernández‐Dueñas Dolores Montero‐Corominas Consuelo Huerta‐Álvarez
The central analgesic tapentadol prolonged release (PR) has proven effective and generally well tolerated in a broad range of chronic pain conditions. Long-term data of its use are still scarce.
Tapentadol PR was well tolerated and equivalent to morphine PR for efficacy and safety in children (6 to 18 years of age) requiring long-term opioid therapy.